Instrument Inactif

Gouvernance NovaBay Pharmaceuticals, Inc. NYSE

US66987P1021

Blockchain & Cryptomonnaies

Cours en clôture NYSE
- ^USD	-

02/10	Principales valeurs en hausse avant l’ouverture	MT
01/10	Principales hausses avant l’ouverture	MT

Comité Exécutif: NovaBay Pharmaceuticals, Inc.

Dirigeant

Fonctions occupéesDepuis

Michael Kazley

35 ans

Chief Executive Officer

16/10/2025

Tommy Law

40 ans

Director of Finance/CFO	15/02/2023
Treasurer	15/02/2023

Henry Blynn

32 ans

Chief Operating Officer

15/07/2026

Composition du Conseil d'Administration: NovaBay Pharmaceuticals, Inc.

Administrateur

ComitésDepuis

Michael Kazley

35 ans

Chairman

16/10/2025

Yen You Zheng

70 ans

Compensation Committee
Audit Committee Chair	31/03/2020
Governance Committee Chair	11/09/2019
Nominating Committee Chair
Audit Committee	15/06/2022
Compensation Committee Chair	15/06/2022

Russell Cann

50 ans

Audit Committee
Compensation Committee
Governance Committee
Nominating Committee

Swan Sit

49 ans

Audit Committee	31/03/2020
Compensation Committee
Governance Committee
Nominating Committee	31/03/2020

David Garcia Rios

30 ans

Director/Board Member	02/09/2026
Independent Dir/Board Member	02/09/2026

Paul Freiman

92 ans

Director/Board Member	16/10/2025
Independent Dir/Board Member	01/05/2002

Anciens Dirigeants et Administrateurs: NovaBay Pharmaceuticals, Inc.

Insider

Fonctions occupées

DepuisJusqu'au

David Lazar

Director/Board Member	19/08/2025	17/10/2025
Chief Executive Officer	19/08/2025	17/10/2025

Yong Xiang Zheng

Director/Board Member

27/01/2022

16/10/2025

Julie Garlikov

Director/Board Member	27/01/2022	16/10/2025
Independent Dir/Board Member	27/01/2022	16/10/2025

Bob Wu

Director/Board Member	26/01/2016	16/10/2025
Independent Dir/Board Member	26/01/2016	16/10/2025

Audrey Kunin

Director/Board Member	27/01/2022	09/06/2023
Corporate Officer/Principal	15/11/2021	05/11/2023

Andrew Jones

Director of Finance/CFO	04/05/2020	15/02/2023
Treasurer	04/05/2020	15/02/2023

Xin Zhou Li

Director/Board Member

10/04/2015

27/01/2022

Wang Xu

General Counsel

01/06/2019

23/07/2021

Xiaopei Wang

Director/Board Member

20/07/2019

21/08/2020

Lynn Christopher

Director of Finance/CFO	18/03/2020	04/05/2020
Treasurer	18/03/2020	04/05/2020

Gail Maderis

Director/Board Member	11/10/2010	31/03/2020
Independent Dir/Board Member	11/10/2010	31/03/2020

Jason Raleigh

Comptroller/Controller/Auditor	01/02/2016	18/03/2020
Director of Finance/CFO	08/03/2019	18/03/2020
Treasurer	08/03/2019	18/03/2020

Todd Zavodnick

Director/Board Member	06/05/2016	11/09/2019
Independent Dir/Board Member	06/05/2016	11/09/2019

Mark Sieczkarek

Director/Board Member	12/03/2019	20/07/2019
Chief Executive Officer	18/11/2015	28/09/2018
Chairman	10/04/2015	12/03/2019
Independent Dir/Board Member	09/01/2014	21/04/2015
President	18/11/2015	28/09/2018

Yan Bin Liu

Director/Board Member

21/03/2018

29/04/2019

Yonghao Ma

Director/Board Member

24/08/2016

29/04/2019

John J. McGovern

Chief Executive Officer	28/09/2018	07/03/2019
Director of Finance/CFO	17/07/2017	07/03/2019
President	28/09/2018	07/03/2019
Treasurer	17/07/2017	07/03/2019

Lewis J. Stuart

Corporate Officer/Principal

01/12/2017

23/07/2018

Henry Liu

Director/Board Member

26/01/2016

21/03/2018

T. McPherson

Director/Board Member	01/07/2006	24/08/2016
Independent Dir/Board Member	01/07/2006	24/08/2016

Massimo Radaelli

Director/Board Member	09/01/2014	06/05/2016
Independent Dir/Board Member	09/01/2014	06/05/2016

Roy Wu

Corporate Officer/Principal

04/08/2009

29/02/2016

Ramin Najafi

Director/Board Member	10/04/2015	18/11/2015
Chief Executive Officer	19/01/2000	18/11/2015
Chairman	01/07/2002	10/04/2015
Founder	28/09/2009	18/11/2015
Public Communications Contact	19/01/2000	25/10/2013
President	01/07/2002	18/11/2015

Charles Cashion

Director/Board Member	01/11/2005	12/06/2015
Independent Dir/Board Member	01/11/2005	12/06/2015

Tony Wicks

Director/Board Member	01/05/2002	12/06/2015
Independent Dir/Board Member	01/05/2002	12/06/2015

Greg Miller

Sales & Marketing

01/01/2015

Glenn Moro

Sales & Marketing

16/07/2014

Bob Tufts

Director/Board Member	01/05/2002	30/06/2014
Independent Dir/Board Member	01/05/2002	30/06/2014

Anthony Dailley

Director/Board Member	01/05/2002	30/06/2014
Independent Dir/Board Member	01/05/2002	30/06/2014

Behzad Khosrovi

Chief Tech/Sci/R&D Officer	01/11/2003	16/11/2009
Corporate Officer/Principal	16/11/2009	31/03/2013

Justin Hall

Director/Board Member	24/08/2020	16/10/2025
Chief Executive Officer	08/03/2019	19/08/2025
Compliance Officer	01/02/2013	08/03/2019
Investor Relations Contact	-	-
General Counsel	01/12/2015	-
President	08/03/2019	19/08/2025
Corporate Secretary	19/08/2025	-

Keith R. Bley

Corporate Officer/Principal

01/01/2013

Russell A. Hoon

Corporate Officer/Principal

30/09/2011

Harry Hixson

Director/Board Member

01/01/2009

19/08/2010

Mark Brian Anderson

Chief Tech/Sci/R&D Officer

30/10/2009

John O'Reilly

Director/Board Member	01/07/2002	31/12/2008
Corporate Officer/Principal	01/07/2002	31/12/2008

Colin Scott

Chief Tech/Sci/R&D Officer

01/01/2006

31/12/2008

Tom Paulson

Comptroller/Controller/Auditor	01/01/2008	-
Director of Finance/CFO	01/01/2008	17/07/2017
Investor Relations Contact	01/01/2008	-
Public Communications Contact	29/04/2010	25/10/2013
Corporate Secretary	29/04/2010	-
Treasurer	01/01/2008	-

Ken Krantz

Chief Tech/Sci/R&D Officer

01/01/2003

Diane M. Cooper

Corporate Officer/Principal

Hagit Glickman

Corporate Officer/Principal

Theresa Granados

Public Communications Contact

Susan Ajay Thomas

Public Communications Contact

29/04/2010

Terri L. Brncic

Comptroller/Controller/Auditor

Ana Kapor

Investor Relations Contact

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	7
Femme	1

Dont comité exécutif

Homme	3
Femme	0

Dont Administrateurs

Homme	5
Femme	1

Stablecoin Development Corporation, anciennement NovaBay Pharmaceuticals, Inc., est une société holding on-chain qui se consacre à une participation à long terme dans des écosystèmes d’actifs numériques alignés sur des protocoles. Son objectif initial en matière d’actifs numériques est l’écosystème du protocole Sky, dont SKY constitue le principal actif. Par le biais du staking et d’autres activités on-chain, la société cherche à générer une exposition économique au niveau du protocole tout en maintenant une gouvernance, une gestion des risques et une discipline propres à une société cotée en bourse. Le protocole Sky est un protocole logiciel décentralisé et sans dépôt, construit autour du stablecoin USDS et régi par les participants à l’écosystème Sky par le biais de processus de gouvernance sur la chaîne. Le protocole est mis en œuvre par le biais de contrats intelligents open source déployés sur la blockchain Ethereum. Le protocole Sky comprend deux jetons natifs principaux : l’USDS, un stablecoin adossé à des garanties et conçu pour maintenir un ancrage souple au dollar américain, et le SKY, le jeton du protocole utilisé dans la gouvernance et certains mécanismes économiques au niveau du protocole.

Employés

Secteur

Blockchain & Cryptomonnaies

Plus d'informations sur la société